Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets
Image for representational purposes only.
| Photo Credit: The Hindu
Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost!-->>-->!-->>-->…